Investigating speech changes in bilinguals as early signs of Alzheimer's disease

Speech Markers of Cognition in Aging Bilingualism

NIH-funded research University of California, San Diego · NIH-10872287

This study is looking at how the way bilingual people speak might change before they show signs of Alzheimer's, hoping to find clues that could help spot the disease earlier, especially for those who speak both Spanish and English.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego NIH-funded
Lab location1 site (La Jolla, United States)
Project IDNIH-10872287 on NIH RePORTER

What this research studies

This research explores how spontaneous speech patterns in bilingual individuals may change years before the onset of Alzheimer's disease. It focuses on identifying specific speech markers, such as simpler sentence structures and increased use of filler words, that could indicate early cognitive decline. By studying Spanish-English bilinguals, the research aims to uncover unique speech characteristics that may differ from those of monolingual speakers. The findings could enhance early diagnosis and understanding of Alzheimer's disease in bilingual populations.

Who could benefit from this research

Good fit: Ideal candidates for this research are Spanish-English bilingual individuals who may be at risk for Alzheimer's disease.

Not a fit: Patients who are monolingual or do not have a family history of Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier and more accurate diagnosis of Alzheimer's disease in bilingual individuals.

How similar studies have performed: While research on speech markers in monolinguals has shown promise, this specific approach in bilinguals is novel and has not been extensively tested.

Where this research is happening

La Jolla, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer disease detectionAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease biological marker
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.